{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:32:17Z","timestamp":1791999137931,"version":"4.4.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00392-023-02314-0","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T13:01:35Z","timestamp":1696510895000},"page":"866-874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adherence to drug therapy in patients with heart failure associated with reduced ejection fractions (HFrEF) during cardiac rehabilitation and after 3 and 6\u00a0months"],"prefix":"10.1007","volume":"113","author":[{"given":"Michal","family":"Oszczygiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"V\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina-Silvia","family":"Popescu-Schuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Schromm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3956-3519","authenticated-orcid":false,"given":"Axel","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"2314_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30\u201341. https:\/\/doi.org\/10.1038\/nrcardio.2010.165","journal-title":"Nat Rev Cardiol"},{"key":"2314_CR2","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine-Skibelund A, ESC Scientific Document Group (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"2314_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.03.006","volume":"6","author":"CW Tsao","year":"2018","unstructured":"Tsao CW, Lyass A, Enserro D, Larson MG, Ho JE, Kizer JR, Gottdiener JS, Psaty BM, Vasan RS (2018) Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction. JACC Heart Fail 6:678685. https:\/\/doi.org\/10.1016\/j.jchf.2018.03.006","journal-title":"JACC Heart Fail"},{"key":"2314_CR4","doi-asserted-by":"publisher","unstructured":"Bundes\u00e4rztekammer (B\u00c4K), Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungsleitlinie Chronische Herzinsuffizienz\u2013Langfassung, 3. Auflage. Version 3. 2019 [cited: 2023\u201303\u201326]. https:\/\/doi.org\/10.6101\/AZQ\/000482.","DOI":"10.6101\/AZQ\/000482"},{"key":"2314_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002606","volume":"5","author":"TM Ruppar","year":"2016","unstructured":"Ruppar TM, Cooper PS, Mehr DR, Delgado JM, Dunbar-Jacob JM (2016) Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials. J Am Heart Assoc 5:e002606. https:\/\/doi.org\/10.1161\/JAHA.115.002606","journal-title":"J Am Heart Assoc"},{"issue":"III","key":"2314_CR6","first-page":"436","volume":"93","author":"A Baessler","year":"2004","unstructured":"Baessler A (2004) Kardiovaskul\u00e4re rehabilitation. MONICA\/KORA-Augsburg-Studiengruppe. Z Kardiol 93(III):436","journal-title":"Z Kardiol"},{"key":"2314_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1185\/03007991003604216","volume":"26","author":"C J\u00fcnger","year":"2010","unstructured":"J\u00fcnger C, Rauch B, Schneider S, Liebhart N, Rauch G, Senges J, Bestehorn K (2010) Effect of early short-term cardiac rehabilitation after acute ST-elevation and non-ST-elevation myocardial infarction on 1-year mortality. Curr Med Res Opin 26:803\u2013811. https:\/\/doi.org\/10.1185\/03007991003604216","journal-title":"Curr Med Res Opin"},{"key":"2314_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1055\/s-2007-1024425","volume":"124","author":"H V\u00f6ller","year":"1999","unstructured":"V\u00f6ller H, Hahmann H, Gohlke H, Klein G, Rombeck B, Binting S, Willich SN (1999) Auswirkung station\u00e4rer Rehabilitation auf kardiovaskul\u00e4re Risikofaktoren bei Patienten mit koronarer Herzerkrankung. PIN-Studiengruppe. Dtsch Med Wochenschr 124:817\u2013823. https:\/\/doi.org\/10.1055\/s-2007-1024425","journal-title":"Dtsch Med Wochenschr"},{"key":"2314_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/VHRM.S276465","volume":"17","author":"J Sch\u00fcrmann","year":"2021","unstructured":"Sch\u00fcrmann J, Noack F, Bethge S, Heinze V, Schlitt A (2021) Patients with heart failure during and after inpatient cardiac rehabilitation. Vasc Health Risk Manag 17:49\u201358. https:\/\/doi.org\/10.2147\/VHRM.S276465","journal-title":"Vasc Health Risk Manag"},{"key":"2314_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1026\/0943-8149\/a000137","volume":"23","author":"R Fuchs","year":"2015","unstructured":"Fuchs R, Klaperski S, Gerber M, Seeling H (2015) Messung der Bewegungs- und Sportaktivit\u00e4t mit dem BSA-Fragebogen: Eine methodische Zwischenbilanz. Z F\u00fcr Gesundheitspsychologie 23:60\u201376. https:\/\/doi.org\/10.1026\/0943-8149\/a000137","journal-title":"Z F\u00fcr Gesundheitspsychologie"},{"key":"2314_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026187","volume":"11","author":"CH Garred","year":"2022","unstructured":"Garred CH, Zahir D, Butt JH, Ravn PB, Bruhn J, Gislason GH, Fosb\u00f8l EL, Torp-Pedersen C, Petrie MC, McMurray JJV, K\u00f8ber L, Schou M (2022) Adherence and discontinuation of optimal heart failure therapies according to age: a Danish nationwide study. J Am Heart Assoc 11:e026187. https:\/\/doi.org\/10.1161\/JAHA.122.026187","journal-title":"J Am Heart Assoc"},{"key":"2314_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004675","volume":"2","author":"LG Gilstrap","year":"2017","unstructured":"Gilstrap LG, Fonarow GC, Desai AS, Liang L, Matsouaka R, DeVore AD, Smith EE, Heidenreich P, Hernandez AF, Yancy CW, Bhatt DL (2017) Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction. J Am Heart Assoc 2:e004675. https:\/\/doi.org\/10.1161\/JAHA.116.004675","journal-title":"J Am Heart Assoc"},{"key":"2314_CR13","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/ejhf.2160","volume":"23","author":"P Gupta","year":"2021","unstructured":"Gupta P, Voors AA, Patel P, Lane D, Anker SD, Cleland JGF, Dickstein K, Filippatos G, Lang CC, van Veldhuisen DJ, Metra M, Zannad F, Samani NJ, Jones DJL, Squire IB, Ng LL (2021) Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study). Eur J Heart Fail 23:1182\u20131190. https:\/\/doi.org\/10.1002\/ejhf.2160","journal-title":"Eur J Heart Fail"},{"key":"2314_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ijcard.2015.03.042","volume":"184","author":"K Krueger","year":"2015","unstructured":"Krueger K, Botermann L, Schorr SG, Griese-Mammen N, Laufs U, Schulz M (2015) Age-related medication adherence in patients with chronic heart failure: a systematic literature review. Int J Cardiol 184:728\u2013735. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.042","journal-title":"Int J Cardiol"},{"key":"2314_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3238\/arztebl.2016.0423","volume":"113","author":"S Unverzagt","year":"2016","unstructured":"Unverzagt S, Meyer G, Mittmann S, Samos FA, Unverzagt M, Prondzinsky R (2016) Improving Treatment Adherence in Heart Failure. Dtsch Arztebl Int 113:423\u2013430. https:\/\/doi.org\/10.3238\/arztebl.2016.0423","journal-title":"Dtsch Arztebl Int"},{"key":"2314_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3238\/arztebl.2015.0527","volume":"112","author":"A Schlitt","year":"2015","unstructured":"Schlitt A, Wischmann P, Wienke A, Hoepfner F, Noack F, Silber RE, Werdan K (2015) Rehabilitation in patients with coronary heart disease: participation and its effect on prognosis. Dtsch Arztebl Int 112:527\u2013534. https:\/\/doi.org\/10.3238\/arztebl.2015.0527","journal-title":"Dtsch Arztebl Int"},{"key":"2314_CR17","doi-asserted-by":"publisher","first-page":"ehad118","DOI":"10.1093\/eurheartj\/ehad118","volume":"11","author":"RS Taylor","year":"2023","unstructured":"Taylor RS, Dalal HM, Zwisler AD (2023) Cardiac rehabilitation for heart failure: \u201cCinderella\u201d or evidence-based pillar of care? Eur Heart J 11:ehad118. https:\/\/doi.org\/10.1093\/eurheartj\/ehad118","journal-title":"Eur Heart J"},{"key":"2314_CR18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1177\/2047487319854140","volume":"27","author":"B Bjarnason-Wehrens","year":"2020","unstructured":"Bjarnason-Wehrens B, Nebel R, Jensen K, Hackbusch M, Grilli M, Gielen S, Schwaab B, Rauch B, German Society of Cardiovascular Prevention and Rehabilitation (DGPR) (2020) Exercise-based cardiac rehabilitation in patients with reduced left ventricular ejection fraction: the Cardiac Rehabilitation Outcome Study in Heart Failure (CROS-HF): a systematic review and meta-analysis. Eur J Prev Cardiol 27:929\u2013952. https:\/\/doi.org\/10.1177\/2047487319854140","journal-title":"Eur J Prev Cardiol"},{"key":"2314_CR19","unstructured":"S3\u2013Leitlinie zur Kardiologischen Rehabilitation (LL-KardReha) im deutschsprachigen Raum Europas, Deutschland, \u00d6sterreich, Schweiz (D-A-CH) AWMF Register-Nr. 133\u2013001. https:\/\/www.awmf.org\/leitlinien\/detail\/ll\/133-001.html"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02314-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02314-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02314-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T07:05:22Z","timestamp":1716275122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02314-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2314"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02314-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"assertion":[{"value":"30 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Klaus Schr\u00f6der have had a financial interest\/arrangement or affiliation with the organizations listed below: Honoraria for lectures: Novartis\u00a9, Pfizer\u00a9, Roche\u00a9, Zoll Medical Corporation\u00a9. Honoraria for advisory board activities: Boehringer-Ingelheim\u00a9, Novartis\u00a9. Irina Silvia Popescu-Schuh have had a financial interest\/arrangement or affiliation with the organizations listed below: Honoraria for lectures: Berlin-Chemie\u00a9. Axel Schlitt have had a financial interest\/arrangement or affiliation with the organizations listed below: Honoraria for lectures: Actelion\u00a9, Astra Zeneca\u00a9, Bayer-Vital\u00a9, Berlin-Chemie\u00a9, Bristol-Myers Squibb\u00a9, Boehringer-Ingelheim\u00a9, Daiichi Sankyo\u00a9, MSD Sharp & Dohme\u00a9, Novartis\u00a9, Pfizer\u00a9, Sanofi-Aventis\u00a9, Servier\u00a9. Honoraria for advisory board activities: Astra Zeneca\u00a9, Boehringer-Ingelheim\u00a9, Novartis\u00a9, Sanofi-Aventis\u00a9. Participation in clinical trials: Astra Zeneca\u00a9, Bayer-Vital\u00a9, Bristol-Myers Squibb\u00a9, Boehringer-Ingelheim\u00a9, Daiichi-Sankyo\u00a9, Lilly\u00a9, Merck\u00a9, MSD Sharp & Dohme\u00a9, Pfizer\u00a9, Roche\u00a9, Sanofi-Aventis\u00a9, Takeda\u00a9.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}